Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of metabolic disorders. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://caranmbv782883.digitollblog.com/38900595/semaglutide-a-potential-solution-for-obesity